230.44 SEK +3.73 +1.65%
Official Close 3/17/2023 BATS Europe


Getinge Analyst Opinions

Getinge Estimates* in SEK

  2023 2024 2025 2026
Revenue - 31,605 33,251 37,494
Dividend 4.52 5.12 5.71 7.45
Dividend Yield (in %) 1.98 % 2.24 % 2.50 % 3.26 %
EPS 11.85 13.53 15.02 22.20
P/E Ratio 19.32 16.92 15.24 10.31
EBIT 4,474 5,105 5,670 7,998
EBITDA - 7,069 7,732 9,845
Net Profit 3,029 3,497 3,922 5,827
Net Profit Adjusted 3,164 3,638 4,101 -
Pre-Tax Profit 4,262 4,910 5,501 7,868
Net Profit (Adjusted) 4,242 4,892 5,462 7,868
EPS (Non-GAAP) ex. SOE - - - -
EPS (GAAP) 11.01 12.79 14.37 21.29
Gross Income 14,836 15,870 17,053 19,634
Cash Flow from Investing -1,216 -1,157 -1,199 -
Cash Flow from Operations 4,313 5,074 5,411 -
Cash Flow from Financing -1,670 -1,579 -1,827 -
Cash Flow per Share 16.13 18.31 20.96 -
Free Cash Flow 3,010 3,720 4,168 -
Free Cash Flow per Share 17.83 19.09 20.69 -
Book Value per Share 117.14 125.10 134.53 -
Net Debt 166 -1,443 -3,460 -
Research & Development Exp. 1,193 1,217 1,264 1,241
Capital Expenditure 1,116 1,239 1,238 -
Selling, General & Admin. Exp. 8,775 9,137 9,603 -
Shareholder’s Equity 32,028 34,222 36,766 -
Total Assets 53,478 55,546 57,640 -
  Previous Quarter
ending 12/31/22
Current Quarter
ending 03/31/23
Next Quarter
ending 06/30/23
Current Year
ending 12/31/24
Next Year
ending 12/31/25
Earnings Estimates
No. of Analysts 5 5 5 11 11
Average Estimate 3.516 SEK 1.839 SEK 2.535 SEK 11.848 SEK 13.527 SEK
Year Ago 4.540 SEK 2.110 SEK 2.330 SEK 10.900 SEK 11.848 SEK
Publish Date 2/1/2023 4/26/2023 7/18/2023 - -
Revenue Estimates
No. of Analysts 6 5 5 11 11
Average Estimate 8,437 SEK 6,623 SEK 7,084 SEK 31,605 SEK 33,251 SEK
Year Ago 7,990 SEK 5,774 SEK 6,670 SEK - 31,605 SEK
Publish Date 2/1/2023 4/26/2023 7/18/2023 - -
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Getinge Dividend Calendar

Date Name Dividend *yield Currency
2022 Getinge AB 4.25 1.96 SEK
2021 Getinge AB 4.00 1.01 SEK
2020 Getinge AB 3.00 1.56 SEK
2019 Getinge AB 1.50 0.86 SEK
2018 Getinge AB 1.00 1.25 SEK
2017 Getinge AB 1.50 1.26 SEK
2016 Getinge AB 1.97 1.37 SEK
2015 Getinge AB 2.80 1.26 SEK
2015 Getinge AB 2.76 1.26 SEK
2014 Getinge AB 2.76 1.57 SEK
2014 Getinge AB 2.80 1.57 SEK
2013 Getinge AB 4.15 1.89 SEK
2013 Getinge AB 4.09 1.89 SEK
2012 Getinge AB 4.15 1.89 SEK
2012 Getinge AB 4.09 1.89 SEK
2011 Getinge AB 3.70 2.15 SEK
2011 Getinge AB 3.75 2.19 SEK
2010 Getinge AB 3.25 2.31 SEK
2010 Getinge AB 3.20 2.31 SEK
2009 Getinge AB 2.71 2.02 SEK
2009 Getinge AB 2.75 2.02 SEK
*Yield of the Respective Date

Getinge AB Calendar

Event Estimate Info Date
Earnings Report 1.839 SEK Q1 2023 Earnings Release 04/26/2023
Annual General Meeting - Annual General Meeting 04/26/2023
Earnings Report 2.535 SEK Q2 2023 Earnings Release 07/18/2023
Earnings Report - Q3 2023 Earnings Release 10/23/2023
Earnings Report - Q4 2023 Earnings Release 01/25/2024
Earnings Report - Q1 2024 Earnings Release 04/23/2024
Earnings Report - Q2 2024 Earnings Release 07/16/2024
Earnings Report - Q3 2024 Earnings Release 10/18/2024

Getinge AB Past Events

Event Actual EPS Info Date
Earnings Report 3.350 SEK Q4 2022 Earnings Release 02/01/2023
Shareholders' Meeting - - 04/26/2022

Getinge Profile

Getinge AB is a medical technology company specializes in providing equipment, systems, operating rooms, intensive-care units to the healthcare and the life science industries. It offers products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. The firm operates through the following segments: Acute Care Therapies, Life Science and Surgical Workflows. The Acute Care Therapies segment offers solutions for life support in acute health conditions. The Life Science segment offers a comprehensive range of equipment, technical expertise and consultation to prevent contamination in biopharmaceutical production, biomedical research, medical device manufacturing and laboratory applications. The Surgical Workflows segment offers products and services for efficient disinfection and sterilization of instruments used in operations, operating tables and other high-quality hardware for operating rooms and advanced IT systems for efficient and secure hospital workflows. The company was founded by Olander Larsson in 1904 and is headquartered in Gothenburg, Sweden. .

Moody’s Daily Credit Risk Score

Risk
  • Low
  • Medium
  • High
4
Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Getinge Shareholder

Owner in %
Freefloat 85.53
Carl Reinhold Adolf Bennet, PhD, MBA 14.30
Fjärde AP-fonden 8.23
Fjarde AP Fonden 8.23
AMF Fonder AB 6.13
Swedbank Robur Fonder AB 3.85
Didner & Gerge Fonder AB 3.64
Incentive AS 2.77
Schroder Investment Management Ltd. 2.69
Norges Bank Investment Management 2.17
Government Pension Fund - Global (The) 2.15
Didner & Gerge Aktiefond 2.10
Carnegie Fonder AB 1.87
The Caisse de dépôt et placement du Québec 1.64
Bernstein Fund Inc. - International Strategic Equities Port. 1.34
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Getinge Management

Name Job
Johan Malmquist Chairman
Carsten Blecker Chief Commercial Officer
Lars Sandström Chief Financial Officer
Henrik Stenmo Chief Financial Officer-Critical Care
Carl Reinhold Adolf Bennet Deputy Chairman
Kristian Samuelsson Director
Åke Larsson Director
Dan Frohm Director
Rickard Karlsson Director
Fredrik Brattborn Director
Magnus Lundbäck Executive VP-Human Resources & Sustainability
Anna Romberg Executive VP-Legal, Compliance & Governance
Joanna Engelke Executive VP-Quality Compliance & Regulatory
Lars Mattsson Head-Investor Relations
Cecilia Margaretha Daun-Wennborg Independent Director
Eva Christina Malin Persson Independent Director
Barbro Fridén Independent Director
Johan Bygge Independent Director
Mattias Sven Perjos President, Chief Executive Officer & Director
Jens Viebke President-Acute Care Therapies Business
Agneta Palmér Vice President-Operational Services